Humana Says Health Law, Hepatitis C Drug Costs Hurt Profit
The insurer says, however, that the increased costs were offset in part by increasing membership.
The Wall Street Journal:
Humana’s Profit Dips In Third Quarter
Humana Inc. said its earnings fell in the most recent quarter as the health insurer continued to feel pressure from costs related to insurance exchanges and new, expensive hepatitis C drugs. The company said these effects were offset in large part by increasing membership, although its results fell below analysts’ expectations. (Calia, 11/7)
Reuters:
Humana Says Profits Fell On ACA Exchanges And Hep C Treatment
Health insurer Humana Inc said on Friday that third-quarter profit fell as it invested in the Obamacare health insurance exchanges and state-based health contracts, and paid for costly hepatitis C treatments. (Humer, 11/7)
